| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 06.05. | Neuland, LIR Life Partner to Advance Cell Penetrating Peptide Platform | ||
| 06.05. | SK pharmteco Greenhouse Gas Emission Reduction Targets Validated by SBTi | ||
| 06.05. | FUJIFILM Biosciences and NextCell Launch Global Research-Use Stromal Cell Platform | ||
| 06.05. | Halozyme Agrees to License Hypercon Technology to Oruka to Develop Psoriasis Treatment | ||
| 06.05. | Symeres Taps Henning Steinhagen as CEO | ||
| 06.05. | Tessera Labs Raises $60 Million to Speed Enterprise Overhauls | ||
| 06.05. | Alcami Acquires Tjoapack | ||
| 06.05. | Bayer Agrees to Acquire Perfuse Therapeutics | ||
| 05.05. | GC Therapeutics Appoints Stefan Irion Chief Scientific Officer | ||
| 05.05. | Epicrispr Biotechnologies and Forge Biologics Announce AAV Development and Manufacturing Pact | ||
| 05.05. | Cellular Origins, Immatics Partner for Automated Cell Therapy Manufacturing | ||
| 05.05. | Tris Pharma Promotes Jim Potenziano to Chief Science and Development Officer | ||
| 05.05. | Schreiner MediPharm, HERMA Partner to Introduce Integrated RFID Labeling Solution | ||
| 05.05. | NewAge Industries Adds AdvantaPure PETG Bottles to Product Line | ||
| 05.05. | HAS Group, Biodelphis Therapeutics Partner to Advance Antibody Protease Inhibitor Conjugates | ||
| 04.05. | Amgen Invests Additional $300 Million in U.S. Manufacturing Network | ||
| 04.05. | Novelty Nobility Expands Manufacturing Pact With AGC Biologics in Japan | ||
| 04.05. | Spruce Biosciences Expands Leadership Team | ||
| 04.05. | Ardena Adds Ben Ash as CFO, Henny Zijlstra as CCO | ||
| 04.05. | Thermo Fisher Scientific Introduces Gibco CTS DynaXS Single Use Bioreactor | ||
| 04.05. | Evotec Nominates Preclinical Development Candidate in Collaboration with Almirall | ||
| 04.05. | UCB Agrees to Acquire Candid Therapeutics | ||
| 04.05. | Novartis to Add New Facility in Morrisville, NC | ||
| 01.05. | Syngene Strengthens Leadership Team | ||
| 01.05. | Siegfried Acquires Noramco, Purisys and Extractas From SK Capital |